Literature DB >> 18984257

Complications with hydroxyapatite cement in mastoid cavity obliteration.

Janell S Ridenour1, Dennis S Poe, David W Roberson.   

Abstract

OBJECTIVE: To determine whether hydroxyapatite (HA) bone cement is a suitable material for mastoid cavity obliteration. STUDY DESIGN &
SETTING: Retrospective case review; tertiary care pediatric hospital. PATIENTS: Three patients, aged 11 to 16 years, underwent canal wall down mastoidectomy for removal of cholesteatomas. INTERVENTION: Mastoid cavity obliteration was performed with hydroxyapatite bone cement. MAIN OUTCOME MEASURES: Failure was defined as the necessity for HA explantation.
RESULTS: All three patients required revision surgery to remove the HA cement. Two patients (one primary and one second look with obliteration) presented with granulations in the mastoid cavity, surrounding the cement. The third patient's intraoperative findings included extensive skull base osteitis with erosion of the posterior and middle fossa dural plates, and fistulae of the lateral and superior semicircular canals. All patients recovered fully after removal of the HA cement.
CONCLUSION: This study raises concerns over the use of HA cement for mastoid cavity obliteration. Three of three implanted patients required revision surgery, two with delayed failure of integration and infection, and one with severe osteitis and significant complications.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18984257     DOI: 10.1016/j.otohns.2008.07.020

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  11 in total

1.  Self-setting calcium orthophosphate formulations.

Authors:  Sergey V Dorozhkin
Journal:  J Funct Biomater       Date:  2013-11-12

Review 2.  Mastoid Obliteration with Synthetic Materials: A Review of the Literature.

Authors:  Charalampos Skoulakis; Petros Koltsidopoulos; Arunachalam Iyer; Georgios Kontorinis
Journal:  J Int Adv Otol       Date:  2019-12       Impact factor: 1.017

3.  Single flap with three pedicles, bone paté and split-thickness skin graft for immediate mastoid obliteration after canal wall down mastoidectomy.

Authors:  Khaled M Mokbel; Yasser W Khafagy
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-11-30       Impact factor: 2.503

4.  A novel method of translabyrinthine cranioplasty using hydroxyapatite cement and titanium mesh: a technical report.

Authors:  Nicholas C Bambakidis; Charles Munyon; Alvin Ko; Warren R Selman; Cliff A Megerian
Journal:  Skull Base       Date:  2010-05

5.  Evaluation of using Bioglass® in obliteration of mastoid cavity.

Authors:  Abdelrahman E M Ezzat; Mustafa I Eid
Journal:  Curr Sci Int       Date:  2014 Apr-Jun

6.  Mid-term outcomes of mastoid obliteration with biological hydroxyapatite versus bioglass: a radiological and clinical study.

Authors:  Sonia Sahli-Vivicorsi; Zarrin Alavi; William Bran; Romain Cadieu; Philippe Meriot; Jean-Christophe Leclere; Rémi Marianowski
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-01-17       Impact factor: 3.236

7.  Canal wall reconstruction in cholesteatoma surgeries: rate of residual.

Authors:  A Roux; D Bakhos; E Lescanne; J-P Cottier; A Robier
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-09-17       Impact factor: 2.503

8.  Mastoid obliteration with silicone blocks after canal wall down mastoidectomy.

Authors:  Sung Woo Cho; Yong-Bum Cho; Hyong-Ho Cho
Journal:  Clin Exp Otorhinolaryngol       Date:  2012-03-22       Impact factor: 3.372

9.  Mastoid obliteration and external auditory canal reconstruction with silicone block in canal wall down mastoidectomy.

Authors:  Mohammad Faramarzi; Reza Kaboodkhani; Ali Faramarzi; Sareh Roosta; Mohammadjavad Erfanizadeh; Milad Hosseinialhashemi
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-09-27

10.  Outcomes of Modified Canal Wall Down Mastoidectomy and Mastoid Obliteration Using Autologous Materials.

Authors:  Bo Gyung Kim; Hyo Jun Kim; Seung Jae Lee; Eunsang Lee; Se A Lee; Jong Dae Lee
Journal:  Clin Exp Otorhinolaryngol       Date:  2019-02-01       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.